A randomized, investigator blind, split-face study of the efficacy of using Eucerin Dermopure to reduce mucocutaneous side effects of adapalene/benzoyl peroxide combination (Epiduo) for the treatment of acne vulgaris.
Phase 3
Completed
- Conditions
- Patient with acne vulgaris.Eucerin Dermopure, irritation, mucocutaneous side effects, acne treatment, acne vulgaris
- Registration Number
- TCTR20230810001
- Lead Sponsor
- Beiresdorf Thailand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Healthy patients with all severity grades of acne vulgaris
Exclusion Criteria
1. Patients with concurrent facial skin infections
2. History of allergy to the study product components.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biophysical changes of skin baseline, 2 weeks, 4 weeks using Corneometer, Tewameter, and Visia
- Secondary Outcome Measures
Name Time Method Patients' assessment score baseline, 2 weeks, 4 weeks grade 0, none; grade 1, mild; grade 2, moderate; grade 3, severe. , Investigator Global Assessment baseline, 2 weeks, 4 weeks investigator global evaluation acne (IGEA) ,Acne lesion counting baseline, 2 weeks, 4 weeks Inflammatory and non-inflammatory acne counting number,Patients' satisfaction score 4 weeks grade 0, minimum; grade 10, maximum.